Genable Technologies

Genable is a specialty biotech company spun out of Trinity College Dublin with significant backing from venture capital investors and a management team with a proven track record of achievements.

Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2
Telephone:+353 (0)1 608 3390
Fax:+353 (0)1 608 3848

Main Contacts
Dr Gearoid Tuohy

Current focus
Genable is commercializing a suite of gene based technologies with the potential to treat more than 100 presently incurable genetic disorders.

The Company's current market focus is on two orphan indications - retinitis pigmentosa and osteogenesis imperfecta.

Genable's underlying platform technology may be applied to a broad range of 'dominant' genetic diseases and is currently being made available for licensing to select industry partners.

Genable controls a broad suite of granted patents and patent applications in the USA, EU and worldwide which open entirely new markets previously ignored due to a lack of appropriate technology. Genable now presents the opportunity to tap this multi-billion euro markets characterised by significant unmet clinical need.